Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function. - Wikidata - wikimedia - TriplyDB

Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function.

Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function.

http://www.wikidata.org/entity/Q30498578

about

Sensitive periods of substance abuse: Early risk for the transition to dependence Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatments Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD).Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models.Methylphenidate and μ opioid receptor interactions: a pharmacological target for prevention of stimulant abuse.Methylphenidate treatment beyond adolescence maintains increased cocaine self-administration in the spontaneously hypertensive rat model of attention deficit/hyperactivity disorder.Long Withdrawal of Methylphenidate Induces a Differential Response of the Dopaminergic System and Increases Sensitivity to Cocaine in the Prefrontal Cortex of Spontaneously Hypertensive Rats.Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.Increased dopamine transporter function as a mechanism for dopamine hypoactivity in the adult infralimbic medial prefrontal cortex following adolescent social stress Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates Adolescent D-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood.Adolescent methylphenidate treatment differentially alters adult impulsivity and hyperactivity in the Spontaneously Hypertensive Rat model of ADHD.Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatments Highly impulsive rats: modelling an endophenotype to determine the neurobiological, genetic and environmental mechanisms of addiction Novelty-induced conditioned place preference, sucrose preference, and elevated plus maze behavior in adult rats after repeated exposure to methylphenidate during the preweanling period.Necessity for research directed at stimulant type and treatment-onset age to access the impact of medication on drug abuse vulnerability in teenagers with ADHD Isolation rearing as a preclinical model of attention/deficit-hyperactivity disorder Adolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: dopamine transporter function and cellular distribution in adulthood.The effects of rearing environment and chronic methylphenidate administration on behavior and dopamine receptors in adolescent rats Lurasidone : in the treatment of schizophrenia.Abuse and dependence liability analysis of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder (ADHD): what have we learned?Exposure to methylphenidate during infancy and adolescence in non-human animals and sensitization to abuse of psychostimulants later in life: a systematic review.Methylphenidate has nonlinear dose effects on cued response inhibition in adults but not adolescents.Gene expression profiling in the striatum of amphetamine-treated spontaneously hypertensive rats which showed amphetamine conditioned place preference and self-administration.Differential sensitivity to the acute and sensitizing behavioral effects of methylphenidate as a function of strain in adolescent and young adult rats.Age-related changes in prefrontal norepinephrine transporter density: The basis for improved cognitive flexibility after low doses of atomoxetine in adolescent rats.Adolescent atomoxetine treatment in a rodent model of ADHD: effects on cocaine self-administration and dopamine transporters in frontostriatal regions.Drugs for kids: good or bad?Blockade of α2-adrenergic receptors in prelimbic cortex: impact on cocaine self-administration in adult spontaneously hypertensive rats following adolescent atomoxetine treatment.Adolescent d-amphetamine treatment in a rodent model of attention deficit/hyperactivity disorder: impact on cocaine abuse vulnerability in adulthood.

P2860

Q28075281-27C09B59-5B54-4875-9DA9-CF5B3A81E09D Q30581979-1A3397AE-79EF-41D2-80A0-FB4DE3303639 Q30582194-6ABBA3CC-B72B-46E7-BB8B-4F2BE6381452 Q34407185-35276573-00CB-4BD3-AD74-D6525FD367B4 Q35016913-1E03F586-2002-49FB-92A0-AC343AE1612D Q35205459-8E557437-2ADE-4F16-93AC-F0E777141AC0 Q35824437-F18462DC-FE91-495D-B8A9-FDE7B8C09F47 Q35908982-14DD4C4C-056F-4FFA-B3DB-06248A7FE544 Q35956198-D6FE497C-49CD-4971-8ACD-BA5C46AC2255 Q36323506-8BDA9756-7E1D-4D34-BA9E-5E1D06E5C2DA Q36372705-6525F7C5-97BA-42B9-95D4-53BF878B1127 Q36611015-7E12390E-561F-413F-9272-80105EF6282F Q36681100-A3DDBA41-537A-4EBA-8D35-F4D4A4881408 Q36683023-527C8A50-5F23-425B-9C93-944B1132F430 Q36796650-ADDF9777-0469-4F5D-97D8-60F4917B29B1 Q36892982-5A9EBC73-0843-4A6D-8A31-C1CF37598F86 Q36912231-739F5F3A-48D8-4B24-A154-6CED2A735260 Q37005445-6C7A92F8-14D8-48AD-8E40-61BFA16997F0 Q37177669-680BEF7D-9359-4D66-91DC-096C4CD097D2 Q38069538-2E6E564D-C33E-4521-A8E3-4D16B139456D Q38087534-838F1867-2FAD-476A-B713-F8B390913D92 Q38656883-AE27FB8A-AA8B-44B8-A31A-403BE0F45A52 Q38901642-DF804F81-4485-479F-AD0D-A958C7DA5C74 Q39138814-A6682994-C829-4E24-84D7-F2C8A6179E69 Q39433547-39FBB2DB-C0EC-4BB3-95C9-353AC2D34FBD Q41967394-CDDA0A3C-C139-4A06-8C05-D3024F6C222F Q42007774-8926D411-0C01-4A74-B803-C5BC589C1A4C Q42326520-323F3123-2A8A-49D3-A5BF-00870E146298 Q48186009-287EAF95-7C5B-4357-B320-B06273924C23 Q48527671-DE1DF42D-DB95-4280-B61E-6AF31EC4A95A

P2860

Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function.

http://www.wikidata.org/entity/Q30498578

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Methylphenidate treatment in a ...... dopamine transporter function.

@ast

Methylphenidate treatment in a ...... dopamine transporter function.

@en

type

label

Methylphenidate treatment in a ...... dopamine transporter function.

@ast

Methylphenidate treatment in a ...... dopamine transporter function.

@en

prefLabel

Methylphenidate treatment in a ...... dopamine transporter function.

@ast

Methylphenidate treatment in a ...... dopamine transporter function.

@en

P1433

Q30498578-8291526C-8D84-49F6-9C98-C74C9FCAD0DA

P1476

Q30498578-1E42EA7E-B2E9-4FB4-BB70-4DC9B4DDDF70

P2093

Q30498578-7906522C-CD88-4F64-B7AE-946AE07C8419

Q30498578-89CFFEEB-1CB9-4EFA-BC84-D1BFAEDC94DC

Q30498578-BF0DD02E-B0D4-4115-9FDA-8265942F50C0

Q30498578-E9E2E0DD-99BF-4104-A476-5F55F8BA0171

Q30498578-FDADE2D7-CF1E-4A2E-91C1-F9B7BEF9FA21

P2860

Q30498578-08AA27C3-413B-4E59-AE7D-CD4E8C61F6AE

Q30498578-0BD8A29C-537F-462B-BA75-2E6D8E436D07

Q30498578-0EB6C31B-6AD7-4B58-9576-3C7B78C72D08

Q30498578-10619EA7-4BC6-4A20-AA90-4593B15A49A1

Q30498578-1145FE8D-9F1A-46E9-B919-F30EBB8BDDC9

Q30498578-133BE27F-A6AE-4FBA-A70A-BF5C06481E24

Q30498578-19495BD4-6982-4085-893F-1C16B1BCF0D7

Q30498578-1CD9C1FF-D1DD-441D-AE0C-7C746F817047

Q30498578-1DA1B356-DBB6-48C4-90A3-FED4E6779675

Q30498578-21484CBD-64E5-4214-B69C-192A6C0DEF14

P2888

Q30498578-CEC9F3CE-9B37-4C58-814B-420D96336049

P304

Q30498578-52B65FF3-E798-4B96-BB70-67EF1E32FB24

P31

Q30498578-3B1FC38E-0D27-4A3C-8F3D-E7D91D9ECEDE

P356

Q30498578-F261B95E-5D69-4199-9A04-E50C42A8812A

P407

Q30498578-18D2CF6E-E25A-4AB7-A97C-B3E258110484

P433

Q30498578-5FE37A13-3561-4236-BB39-C51F44A94F6D

P478

Q30498578-6F615BE2-7014-4429-A942-B0857CBB11B2

P577

Q30498578-1CEBBE5B-742C-45CA-AA8F-9B684D053EFA

P5875

Q30498578-E0576B98-3BD2-4670-AFF9-4DC7289B67F8

P6179

Q30498578-73053319-6F3F-4012-BA39-CFA41F9337E6

P698

Q30498578-E8A8BE7E-44D8-49D8-9FB7-F6DFD768A3C5

P921

Q30498578-2E3726F1-2A82-47D4-9B05-B0902DC8138D

Q30498578-71dc586d-edf0-4dea-b410-513ac9dcb09f

Q30498578-81DE3819-370D-4A23-B020-42C63CE4F90C

Q30498578-D60D017C-4A50-4BBB-A4F3-ED0801E6100B

P932

Q30498578-48E310B3-3647-4748-8BB7-E3C4D5EB6EAE

P356

P1433

Neuropsychopharmacology

P1476

Methylphenidate treatment in a ...... dopamine transporter function.

@en

P2093

Agripina Deaciuc

http://www.w3.org/2001/XMLSchema#string

Kathleen M Kantak

http://www.w3.org/2001/XMLSchema#string

Linda P Dwoskin

http://www.w3.org/2001/XMLSchema#string

Roxann C Harvey

http://www.w3.org/2001/XMLSchema#string

Sucharita Sen

http://www.w3.org/2001/XMLSchema#string

P2860

A qualitative review of issues arising in the use of psychostimulant medications in patients with ADHD and co‑morbid substance use disorders

The spontaneously hypertensive rat model of ADHD--the importance of selecting the appropriate reference strain

Sequence analysis of Drd2, Drd4, and Dat1 in SHR and WKY rat strains.

Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines

Altered dopamine transporter function and phosphorylation following chronic cocaine self-administration and extinction in rats

Medial temporal lobe functioning and structure in the spontaneously hypertensive rat: comparison with Wistar-Kyoto normotensive and Wistar-Kyoto hypertensive strains.

Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study.

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.

Effects of self-administered cocaine in adolescent and adult male rats on orbitofrontal cortex-related neurocognitive functioning

Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals.

P2888

P304

837-847

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NPP.2010.223

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49676687

http://www.w3.org/2001/XMLSchema#string

P6179

1030353736

http://www.w3.org/2001/XMLSchema#string

P698

21150910

http://www.w3.org/2001/XMLSchema#string

P921

P932

3055734

http://www.w3.org/2001/XMLSchema#string